Provided by Tiger Fintech (Singapore) Pte. Ltd.

The Oncology Institute

3.97
+0.890028.90%
Volume:8.65M
Turnover:33.83M
Market Cap:390.57M
PE:-5.90
High:4.18
Open:3.17
Low:3.14
Close:3.08
52wk High:4.88
52wk Low:0.1253
Shares:98.38M
Float Shares:82.44M
Volume Ratio:3.18
T/O Rate:10.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6732
EPS(LYR):-0.7063
ROE:-651.69%
ROA:-17.27%
PB:-43.47
PE(LYR):-5.62

Loading ...

Company Profile

Company Name:
The Oncology Institute
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
825
Office Location:
18000 Studebaker Road,Suite 800,Cerritos,California,United States
Zip Code:
90703
Fax:
- -
Introduction:
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Directors

Name
Position
Brad Hively
Vice Chairman of the Board
Daniel Virnich
Director, President and Chief Executive Officer
Anne McGeorge
Chair
Gabriel Ling
Independent Director
Karen M. Johnson
Independent Director
Mark L. Pacala
Independent Director
Mohit Kaushal
Independent Director

Shareholders

Name
Position
Daniel Virnich
Director, President and Chief Executive Officer
Robert Ross Carter
Chief Financial Officer and Principal Accounting Officer
Yale Podnos
Chief Medical Officer